(Q74597412)
Statements
A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer (English)
Anthony W Tolcher
Leonard Reyno
Peter M Venner
Scott D Ernst
Malcolm Moore
Richard S Geary
Kim Chi
Sean Hall
Wendy Walsh
Andrew Dorr
Elizabeth Eisenhauer
1 August 2002